Overview
The FDA’s 2026 briefing describes BPC-157 as a fifteen-residue peptide and discusses its free-base and acetate forms separately. The common name needs to be read alongside the specified chemical form.
Identity & classification
- NAME
- BPC-157
- RESEARCH CATEGORY
- TISSUE-REPAIR RESEARCH
- MOLECULAR CLASS
- Fifteen-residue peptide
- KEY DISTINCTION
- Distinguish the free-base and salt forms
Reading the evidence
Identify the name, chemical form, sample identifier and subject of the report. The research category organizes references rather than establishing a clinical effect. An advisory-committee briefing is not itself a final regulatory determination.